Thierry Billard Selected Research

Thierry Billard Research Topics

4	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2014
3	Synucleinopathies 01/2018 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2018 - 01/2014
2	Mood Disorders (Mood Disorder) 11/2011 - 08/2011
1	Dyskinesias (Dyskinesia) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Multiple Sclerosis 01/2019
1	Multiple System Atrophy 01/2018
1	Autism Spectrum Disorder 12/2017
1	Epilepsy (Aura) 01/2014
1	Pain (Aches) 01/2014

3	5-HT1A Serotonin ReceptorIBA 01/2021 - 10/2014
2	Serotonin 5-HT1 Receptor AntagonistsIBA 01/2021 - 10/2014
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 07/2018
2	RadiopharmaceuticalsIBA 01/2020 - 10/2016
2	alpha-SynucleinIBA 01/2018 - 01/2014
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	serotonin 6 receptorIBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2018
1	2- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazoleIBA 01/2018
1	Amyloid beta-PeptidesIBA 01/2018
1	SynucleinsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Dopa DecarboxylaseIBA 01/2018
1	Oxytocin (Pitocin)FDA LinkGeneric 12/2017
1	Serotonin ReceptorsIBA 10/2014
1	Antidepressive Agents (Antidepressants)IBA 11/2011
1	Pharmaceutical PreparationsIBA 08/2011
1	serotonin 7 receptorIBA 08/2011

1	Drug Therapy (Chemotherapy) 01/2014